Published September 13, 2021 by NORD
The Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®) is an FDA-funded initiative with the goal of accelerating therapy development across rare diseases.
Read morePublished June 1, 2021 by NORD
Published January 25, 2021 by NORD
On January 22, NORD’s Rare Caregiver Respite Program was featured in an article by BioNews Service writer Mary Chapman detailing the program’s offerings. It has run in the following patient-focused …
Continue reading “NORD’s Rare Caregiver Respite Program Featured in BioNews Service Newsletters”
Read moreEvery day matters for patients, researchers, and families who rely on NORD's trusted information.
We can’t keep these resources free and growing without your help.
Please donate today — and power the future of rare disease progress.
Whether you’re a patient, researcher, student, or advocate — we’re here for you.
If you’ve found NORD’s resources helpful, please consider donating.
Your support keeps this information free, updated, and available for everyone who needs it.